Home › Parkinson's Disease › Oklahoma
Parkinson's Disease clinical trials in Oklahoma
4 studies for Parkinson's Disease are looking for participants at sites in Oklahoma.
Cities in Oklahoma
A Study of Buntanetap in Participants With PD
- The Movement Disorder Clinic of Oklahoma, Tulsa
RecruitingPhase 2/3
Ages 40 to 85 · All sexes · Updated Sep 21, 2026 · NCT07284784A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- The Movement Disorder Clinic of Oklahoma, Tulsa
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Sep 3, 2026 · NCT07174310A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- The Movement Disorder Clinic of Oklahoma, Tulsa
RecruitingPhase 2
Ages 40 to 80 · All sexes · Updated Aug 28, 2026 · NCT06680830A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
- The Movement Disorder Clinic of Oklahoma, Tulsa
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Aug 24, 2025 · NCT06765668From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.